Skip to content

View Spec Sheet

open_in_new
  1. Shop all
  2. Peptides

GTX88429-PEP

p14ARF (isoform 3) blocking peptide

Cannot supply to this region.

SKU:
GTX88429-PEP
Additional Names:
MLM blocking peptide , P16INK4 blocking peptide , P14ARF blocking peptide , CMM2 blocking peptide , CDKN2A blocking peptide , P16 blocking peptide , TP16 blocking peptide , CDKN2 blocking peptide , P14 blocking peptide , P19ARF blocking peptide , ARF blocking peptide , INK4A blocking peptide , INK4 blocking peptide , P16INK4A blocking peptide , CDK4I blocking peptide , MTS1 blocking peptide , P19 blocking peptide
Physical State:
Lyophilized
Storage Conditions:
-20[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted., 2-8[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted., -20[o]C/-70[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted.
Supplier:
Genetex
Buffer:
Reconstitute with 200ul distilled water to obtain a 0.5mg/ml peptide solution. Lyophilized from 5% (v/v) acetonitrile/H₂O, no preservatives.
Immunogen:
cyclin-dependent kinase inhibitor 2A
Species:
Human
Synonyms:
alternative reading frame;ARF;CDK4 inhibitor p16-INK4;CDK4I;CDKN2;cell cycle negative regulator beta;CMM2;cyclin-dependent kinase 4 inhibitor A;cyclin-dependent kinase inhibitor 2A;cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4);INK4;INK4A;MLM;MTS-1;MTS1;multiple tumor suppressor 1;P14;P14ARF;P16;P16-INK4A;P16INK4;P16INK4A;P19;P19ARF;TP16
Extra Details:
This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012]
Shipping Conditions:
Blue Ice